Invention Grant
US09579314B2 Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
有权
具有毒蕈碱受体拮抗剂和BETA2肾上腺素受体激动剂活性的化合物
- Patent Title: Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
- Patent Title (中): 具有毒蕈碱受体拮抗剂和BETA2肾上腺素受体激动剂活性的化合物
-
Application No.: US15040382Application Date: 2016-02-10
-
Publication No.: US09579314B2Publication Date: 2017-02-28
- Inventor: Fabio Rancati , Andrea Rizzi , Laura Carzaniga , Ian Linney , Chris Knight , Wolfgang Schmidt
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP15154917 20150212
- Main IPC: C07D453/02
- IPC: C07D453/02 ; A61K31/4704 ; C07D403/12 ; C07D401/14 ; A61K31/4709 ; C07D401/12 ; C07D453/04 ; A61K9/00 ; A61K31/496 ; A61K45/06 ; C07D215/227 ; C07D409/14 ; C07D471/10 ; C07D487/04 ; C07D487/10 ; C07D498/10
Abstract:
Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating broncho-obstructive and inflammatory diseases.
Public/Granted literature
- US20160235734A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Public/Granted day:2016-08-18
Information query
